Description
LXH254 is a type II RAF inhibitor.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LXH254 is a type II RAF inhibitor.
| Cas No. | 1800398-38-2 |
|---|---|
| Purity | ≥99% |
| Formula | C25H25F3N4O4 |
| Formula Wt. | 502.49 |
| IUPAC Name | N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
| Synonym | Naporafenib |
| Appearance | White powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Monaco K, Delach S, Yuan J, et al. LXH254, a potent and selective ARAF-sparing inhibitor of BRAF and CRAF for the treatment of MAPK-driven tumors. Clin Cancer Res. 2021 Apr 1;27(7):2061-2073. PMID: 33355204
Park S, Kim T, Cho S, et al. Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells. Cancer Lett. 2020 Dec 28;495:135-144. PMID: 32979462
Fluoroquinolone; topoisomerase IV and bacterial...
Cyclosporin metabolite; weak calmodulin inhibit...
Rapamycin analog
β-adrenergic antagonist.
Resveratrol prodrug; potential SIRT1 activator....
Flavonoid found in Scutellaria; CDK9 inhibitor....
Somewhat selective in inhibiting COX-2 over COX...
Carotenoid found in shrimp, salmon, and algae.<...
PDE5 inhibitor.
PI3K and mTOR inhibitor.
Polyphenolic compound present in black tea.
Impurity of omeprazole
Isoquinoline alkaloid found in a variety of pla...
Macrocyclic lactone.
Kv7 K+ channel activator, NMDA antagonist, GABA...
ALK5 (activin-like) inhibitor.
CDK4/6 inhibitor.
Calcitonin-family peptide, involved in vasodila...
Peptide, derivative of AT II, involved in vasoc...
Melatonin analog; MT1/2 agonist.